Spotlights
Christa Pawlowski turns Ohio research into lifesaving technology
Haima Therapeutics co-founder Christa Pawlowski is developing SynthoPlate, a synthetic, shelf-stable drug that stops severe bleeding. By transforming Case Western research into lifesaving tech, she is helping establish Ohio as a premier hub for scaling global life science companies.